Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial

B Chevalier, Yoshinobu Onuma, AJ van Boven, JJ Piek, M Sabate, S Helqvist, A Baumbach, PC Smits, R Kumar, L Wasungu, PWJC Serruys

Research output: Contribution to journalArticleAcademicpeer-review

49 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1102-1107
Number of pages6
Issue number9
Publication statusPublished - 2016

Cite this